Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies

HIGHLIGHTS

  • Who: Simona Gurzu from the Department of Pathology, Pharmacy, Science and Technology, George Emil Palade University of Medicine, Gheorghe Marinescu Street, Targu Mures, Romania have published the research: Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies, in the Journal: (JOURNAL)
  • How: Later data showed that many patients had a history of cirrhosis (8-67%) chronic hepatitis B (9-70%) hepatitis_C (1-17%) combined hepatitis B and C (6%) or alcohol abuse (7%) (Lee et_al 2006 2013 Yin et_al 2012 Li et_al 2016 Wu et_al 2016 Zhao et_al 2016). As discussed later in . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?